Canopy Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.32M Sell
13,071
-44
-0.3% -$10.3K 1% 23
2026
Q1
$3.21M Sell
13,115
-374
-3% -$87.1K 1.1% 23
2025
Q4
$2.79M Sell
13,489
-130
-1% -$25.7K 0.91% 25
2025
Q3
$2.53M Sell
13,619
-97
-0.7% -$16.6K 0.84% 27
2025
Q2
$2.1M Sell
13,716
-336
-2% -$51.6K 0.77% 29
2025
Q1
$2.33M Sell
14,052
-517
-4% -$80.9K 0.91% 27
2024
Q4
$2.11M Buy
14,569
+795
+6% +$123K 0.8% 28
2024
Q3
$2.23M Buy
13,774
+77
+0.6% +$12.3K 0.96% 20
2024
Q2
$2M Buy
13,697
+187
+1% +$27.8K 0.93% 19
2024
Q1
$2.14M Buy
13,510
+583
+5% +$92.8K 1.04% 17
2023
Q4
$2.03M Buy
+12,927
New +$1.98M 1.23% 16

Other funds holding JNJ

Canopy Partners's JNJ Position: Q2 2026 in Review

Canopy Partners reduced its Johnson & Johnson (JNJ) stake by 0.34% in Q2 2026, selling an estimated $10.3K and leaving 13,071 shares worth $3.32M. The position accounts for 1% of the portfolio, ranked #23.

Canopy Partners first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Canopy Partners held 13,071 shares of Johnson & Johnson worth $3.32M as of Q2 2026.
  • Canopy Partners sold 44 Johnson & Johnson shares in Q2 2026, an estimated $10.3K.
  • Johnson & Johnson made up 1% of Canopy Partners's portfolio in Q2 2026, its #23 holding.
  • Canopy Partners first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Canopy Partners's 13F filing for Q2 2026, filed 22 Jul 2026.